Fresh Recalls

FDAClass II · Drug · Recall D-0547-2026 · Recalled May 20, 2026

Ascend Laboratories recall — Ascend Laboratories, LLC

Agency report date: May 20, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Ascend Laboratories
Company / brand
Ascend Laboratories
Lot / serial / date codes
Lot # 25140859; Exp. Date: Jan 2027
Distribution
U.S. Nationwide
Agency product description and boundaries

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Dissolution Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Ascend Laboratories

3. Open the official notice or contact

Official recall ID
D-0547-2026
Brand
Ascend Laboratories
Classification
Class II
Units affected
17,304 100-count bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Bedminster, NJ, United States
Firm address
135 Us Highway 202 206 Ste 15, 07921-2608

Identifying details (verbatim from the notice)

Product codes / lots
Lot # 25140859; Exp. Date: Jan 2027
Distribution
U.S. Nationwide
Firm notified the public via
Letter
FDA event ID
98821
Recall initiated
April 27, 2026
FDA classified
May 20, 2026
FDA report date
May 20, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved August 18, 2026 at 6:00 PM UTC.

Report a data error on this page